APA (7th ed.) Citation

SM, U., S, K., SR, M., A, G., SVS, D., S, P., & CP, P. (2026). β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939. Technology in cancer research & treatment, 25, 15330338261425407. https://doi.org/10.1177/15330338261425407

Chicago Style (17th ed.) Citation

SM, Umar, Kahol S, Mathur SR, Gogia A, Deo SVS, Pandey S, and Prasad CP. "β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939." Technology in Cancer Research & Treatment 25 (2026): 15330338261425407. https://doi.org/10.1177/15330338261425407.

MLA (9th ed.) Citation

SM, Umar, et al. "β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939." Technology in Cancer Research & Treatment, vol. 25, 2026, p. 15330338261425407, https://doi.org/10.1177/15330338261425407.